Degarelix Acetate Before and During Radiation Therapy in Treating Patients With Prostate Cancer
Status:
Completed
Trial end date:
2016-09-01
Target enrollment:
Participant gender:
Summary
This pilot clinical trial studies how well degarelix acetate before and during radiation
therapy works in treating patients with prostate cancer. Androgens can cause the growth of
prostate cancer cells. Drugs, such as degarelix acetate, may lessen the amount of androgens
made by the body. Radiation therapy uses high energy x-rays to kill tumor cells and shrink
tumors. Giving degarelix acetate together with radiation therapy may work better in treating
prostate cancer.